The effects of teneligliptin on cardiac function and endothelial function in patients with type 2 diabetes
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000012120
- Lead Sponsor
- Dokkyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Type-1 diabetes, diabetes due to a pancreatic disorder, or secondary diabetes due to conditions such as Cushing's syndrome and acromegaly 2)Application of contraindications contained in the package insert 3)Heart failure (NYHA grade 3-4) 4)Patients prone to QT prolongation 5)Excessive alcohol consumption 6)Pregnant women, women suspected of being pregnant, or lactating women 7)History of myocardial infarction 8)The medication in the treatment of diabetes drugs not be used with insurance 9)Under administration of GLP-1 agonists
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method